Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data
Recruiting
Observational Study
Ovarian Cancer
Image
Predation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Female
- Study type
- Observational
- Participants needed
- 146 (estimated)
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This project intends to conduct a multicenter retrospective study to evaluate the satisfactory reduction of advanced ovarian cancer using PET-CT images, and explore the correlation between molecular biological characteristics and clinical characteristics of ovarian cancer through high-throughput sequencing genomics combined with radiomics.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pathological type is epithelial ovarian cancer.
* Underwent primary debulking surgery at our hospital.
* Postoperative pathological staging is FIGO stage IIB or above.
* Clinical, surgical, and pathological data of the patient are mostly complete.
Exclusion Criteria:
* Patho…
Contacts